K12.31 – Oral mucositis (ulcerative) due to antineoplastic therapy
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
Additional
code for adverse effect, if applicable, to identify antineoplastic and immunosuppressive drugs (T45.1X5)
GEM Conversion to ICD-9 CM
MDC / MS-DRG Reference
Back Reference of Diagnostic Codes
Sibling Codes
Parent Sibling Codes
View in Tabular
Code | Title |
---|---|
K00-K95 | Diseases of the digestive system (K00-K95) |
K00-K14 | Diseases of oral cavity and salivary glands (K00-K14) |
K12 | Stomatitis and related lesions |
K12.3 | Oral mucositis (ulcerative) |
K12.31 |
Oral mucositis (ulcerative) due to antineoplastic therapy
Use Additional
code for adverse effect, if applicable, to identify antineoplastic and immunosuppressive drugs (T45.1X5)
|